GROV Form 4: John Replogle reports 3,920 RSUs vested, no expiration
Rhea-AI Filing Summary
Grove Collaborative Holdings director John B. Replogle received 3,920 restricted stock units (RSUs) that vested on 08/15/2025, each representing a contingent right to one share of Class A Common Stock. After the reported transaction, Mr. Replogle beneficially owns 501,779 shares of Class A Common Stock directly and an additional 53 shares indirectly held by Replogle Family LLC, which he manages. The RSUs have no expiration date and follow a previously disclosed vesting schedule that began with 30% vesting on November 15, 2022, followed by quarterly vesting amounts thereafter.
Positive
- Director received vested RSUs that convert to 3,920 Class A shares, reflecting continued alignment with shareholders
- Total direct beneficial ownership reported at 501,779 Class A shares following the transaction
- RSUs have no expiration date, indicating long-term alignment and retention mechanism
Negative
- None.
Insights
TL;DR: Routine insider vesting resulted in 3,920 RSUs converting to beneficial ownership, a non-material increase for investors.
The transaction reflects scheduled vesting of previously granted RSUs rather than an opportunistic purchase or sale. The report shows the RSUs convert one-for-one into Class A shares and that the reporting person remains a significant holder with 501,779 shares. This is a routine compensation-related issuance with no stated price or cash consideration and no expiration date, indicating long-term alignment of the director with the company.
TL;DR: Vesting of previously disclosed RSUs for a director indicates standard equity compensation and continued alignment with shareholders.
The filing confirms the reporting person serves as a director and as manager of an entity holding indirect shares. The RSU vesting schedule disclosed in the form shows staged vesting beginning November 15, 2022. The filing is procedural and consistent with standard governance practices for executive/director equity awards; no departures, option exercises, or atypical transactions are disclosed.
FAQ
What transaction did John B. Replogle report on Form 4 for GROV?
How many Grove Collaborative (GROV) shares does the reporting person beneficially own after the transaction?
When did the RSU vesting schedule begin and what were early vesting terms?
Do the RSUs reported on the Form 4 expire?
Who signed the Form 4 for John B. Replogle and when?